Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



3D Bioprinting of Biomimetic Alginate/Gelatin/Chondroitin Sulfate Hydrogel Nanocomposites for Intrinsically Chondrogenic Differentiation of Human Mesenchymal Stem Cells
Indexado
WoS WOS:001225253000001
Scopus SCOPUS_ID:85192828266
DOI 10.1021/ACS.BIOMAC.3C01444
Año 2024
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



3D-printed hydrogel scaffolds biomimicking the extracellular matrix (ECM) are key in cartilage tissue engineering as they can enhance the chondrogenic differentiation of mesenchymal stem cells (MSCs) through the presence of active nanoparticles such as graphene oxide (GO). Here, biomimetic hydrogels were developed by cross-linking alginate, gelatin, and chondroitin sulfate biopolymers in the presence of GO as a bioactive filler, with excellent processability for developing bioactive 3D printed scaffolds and for the bioprinting process. A novel bioink based on our hydrogel with embedded human MSCs presented a cell survival rate near 100% after the 3D bioprinting process. The effects of processing and filler concentration on cell differentiation were further quantitatively evaluated. The nanocomposited hydrogels render high MSC proliferation and viability, exhibiting intrinsic chondroinductive capacity without any exogenous factor when used to print scaffolds or bioprint constructs. The bioactivity depended on the GO concentration, with the best performance at 0.1 mg mL(-1). These results were explained by the rational combination of the three biopolymers, with GO nanoparticles having carboxylate and sulfate groups in their structures, therefore, biomimicking the highly negatively charged ECM of cartilage. The bioactivity of this biomaterial and its good processability for 3D printing scaffolds and 3D bioprinting techniques open up a new approach to developing novel biomimetic materials for cartilage repair.

Revista



Revista ISSN
Biomacromolecules 1525-7797

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Biochemistry & Molecular Biology
Chemistry, Organic
Polymer Science
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 OLATE-MOYA, FELIPE ANDRES Hombre Universidad de Chile - Chile
Ctr Intervent Med Precis & Adv Cellular Therapy - Chile
IMPACT - Chile
2 Rubi-Sans, Gerard - Barcelona Inst Sci & Technol BIST - España
CIBER BBN - España
Instituto de Bioingeniería de Cataluña - España
BBN Technologies - Estados Unidos
3 Engel, Elisabeth Mujer Barcelona Inst Sci & Technol BIST - España
CIBER BBN - España
Univ Politecn Catalunya UPC - España
Universitat Politècnica de Catalunya - España
Instituto de Bioingeniería de Cataluña - España
BBN Technologies - Estados Unidos
4 Mateos-Timoneda, Miguel Angel Hombre Univ Int Catalunya - España
Universitat Internacional de Catalunya - España
5 PALZA-CORDERO, HUMBERTO CRISTIAN Hombre Universidad de Chile - Chile
Ctr Intervent Med Precis & Adv Cellular Therapy - Chile
IMPACT - Chile

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
European Regional Development Fund
Generalitat de Catalunya
Ministerio de Ciencia, Innovacion y Universidades
Agencia Estatal de Investigación
FEDER, UE
Fondo Nacional de Desarrollo Cient?fico y Tecnol?gico
Agencia Nacional de Investigación y Desarrollo
PRTR
European Union's Horizon Europe research and innovation programme
Union Europea NextGenerationEU/PRTR
European Union’s Horizon Europe research and innovation programme
Unión Europea NextGenerationEU
ANID-Basal Center of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT
ANID under FONDEQUIP Projects
Icrea Academia 2022
Severo Ochoa Unit of Excellence
Programme/Generalitat de Catalunya
Programme

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
The authors are thankful for the financial support from ANID under FONDEQUIP Projects EQM150101 and EQM140012 and project ANID-Basal Center of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, # FB210024. F.O.M. thanks ANID (ex CONICYT) Beca de Doctorado Nacional 21150039 and FONDECYT de Postdoctorado 3240135. E.E. thanks the European Union's Horizon Europe research and innovation programme under grant agreement No. 101098972 (BIOACTION), Programme/Generalitat de Catalunya (2021 SGR 00387) and Severo Ochoa Unit of Excellence (CEX2018-000, 789-S, 2019-2023) and Icrea Academia 2022. M.A.M.T. thanks MICIU/AEI 10.13039/501100011033 and FEDER, UE for funding project PID2022-137962OB-I00, MICIU/AEI/10.13039/501100011033 and Union Europea NextGenerationEU/PRTR for funding project PLEC2022-009279, and Programme/Generalitat de Catalunya (2021 SGR 00565). The TOC graphic was created using BioRender.
The authors are thankful for the financial support from ANID under FONDEQUIP Projects EQM150101 and EQM140012 and project ANID-Basal Center of Interventional Medicine for Precision and Advanced Cellular Therapy, IMPACT, # FB210024. F.O.M. thanks ANID (ex CONICYT) Beca de Doctorado Nacional 21150039 and FONDECYT de Postdoctorado 3240135. E.E. thanks the European Union\u2019s Horizon Europe research and innovation programme under grant agreement No. 101098972 (BIOACTION), Programme/Generalitat de Catalunya (2021 SGR 00387) and Severo Ochoa Unit of Excellence (CEX2018-000, 789-S, 2019-2023) and Icrea Academia 2022. M.A.M.T. thanks MICIU/AEI 10.13039/501100011033 and FEDER, UE for funding project PID2022-137962OB-I00, MICIU/AEI/10.13039/501100011033 and Unio\u0301n Europea NextGenerationEU/PRTR for funding project PLEC2022-009279, and Programme/Generalitat de Catalunya (2021 SGR 00565). The TOC graphic was created using BioRender.

Muestra la fuente de financiamiento declarada en la publicación.